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Shogo Banno1 and Hirokazu Imai1*Abstract
Background: Focal segmental glomerulosclerosis-like lesions have been proposed to be predictive factors for IgA
nephropathy. This single center, retrospective cohort study was designed to clarify which clinical and pathological
factors are predictive of decreased estimated glomerular filtration rate (eGFR) at 5 and 10 years in IgA nephropathy
patients.
Methods: Of the 229 patients with IgA nephropathy who were admitted to Aichi Medical University Hospital
between 1986 and 2010, 57 were included in this study during the 5 to 10 years after renal biopsy. Clinical,
laboratory, and pathological parameters were analyzed by multiple linear regression analysis with backward
elimination to determine independent risk factors. After identifying such factors, we compared patients with and
without each factor using the Student’s t test, Wilcoxon test, or Mann–Whitney U test.
Results: Four variables were identified as predictive factors for progression of IgA nephropathy: initial eGFR
(p = 0.0002), glomerular tip adhesion (p = 0.004), global sclerosis (p = 0.019), and diastolic blood pressure (p = 0.024).
The annual decrease in eGFR of patients with (n = 9) or without glomerular tip adhesions (n = 48) was 4.13 ± 3.58
and 1.49 ± 2.89 ml/min/1.73 m2, respectively (p = 0.015). Serum total cholesterol levels were 231 ± 45 mg/dl and
196 ± 42 mg/dl, respectively (two-sided p = 0.064; one-sided p = 0.032).
Conclusions: The presence of glomerular tip adhesions predicts the progression of IgA nephropathy. High levels of
serum total cholesterol may affect glomerular tip adhesions.Background
IgA nephropathy is the most common glomeruloneph-
ritis, defined as predominantly IgA deposition in the
mesangial area with mesangial proliferation. It varies
from mild focal segmental proliferation to severe diffuse
global proliferation with crescent formation. Many stud-
ies examining the relationship between the histopatho-
logical features of IgA nephropathy and clinical outcome
suggest that glomerulosclerosis and interstitial fibrosis
are predictive of poor prognosis [1]. Mesangial hypercellu-
larity [2,3], crescent formation [4-6], capillary wall IgA de-
position [4,7], and focal segmental glomerulosclerosis
(FSGS)-like lesions [8,9] have been suggested as histo-
logical risk factors for progressive renal failure in IgA ne-
phropathy. Recently, FSGS-like lesions [10] and collapsing* Correspondence: imaihiro@aichi-med-u.ac.jp
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reproduction in any medium, provided the orand cellular types of FSGS [11] have been proposed as
predictive factors. These apparently conflicting results re-
flect differences in patient cohort, treatment, and clinical
outcome measures. When the clinical end point is time to
dialysis or renal failure, or serum creatinine doubling time,
chronic lesions such as tubular atrophy, interstitial fibro-
sis, and glomerulosclerosis are identified as risk factors. If
a decrease in the glomerular filtration rate (GFR) in early-
stage disease is the chosen end point, other predictive fac-
tors may be identified. Idiopathic FSGS is classified into
several subtypes such as the glomerular tip variant, cellu-
lar variant, collapsing variant, perihilar variant, and not
otherwise specified (NOS) [12]. Within glomerular tip
lesions, there are glomerular tip prolapse, glomerular tip
adhesion, glomerular tip sclerosis, and glomerular tip
foam cells. There are no data on which histological char-
acteristics of FSGS are relevant to the progression of IgA
nephropathy, although one study suggested the import-
ance of the collapsing and cellular variants [11].Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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study to clarify which clinical and pathological factors
are predictive of decreased eGFR in patients with IgA
nephropathy at 5 and 10 years after renal biopsy, which
includes an analysis of many pathological findings re-
lated to FSGS-like lesions.
Methods
The present retrospective cohort study was approved by
the Ethics Committee of Aichi Medical University.
Of the 821 patients who underwent renal biopsy
between 1986 and 2010 at Aichi Medical University
Hospital, 229 patients (27.9%) were diagnosed with IgA
nephropathy based on the light microscopic and im-
munofluorescent study findings. In this group, 57 had
sufficient clinical, laboratory, and pathological data and
5 to 10 years of follow-up (Figure 1).
Analysis of clinical and laboratory data
We collected clinical and laboratory data from medical
charts or computer-based data storage in the hospital,
including the age at renal biopsy, sex, systolic blood
pressure, diastolic blood pressure, dairy amount of urin-
ary protein, degree of hematuria, total protein, serum al-
bumin, blood urea nitrogen, creatinine, total cholesterol,
initial estimated glomerular filtration rate (eGFR), and
final eGFR, which were calculated using the 4-variable
Modification of Diet in Renal Disease (MDRD) Study
equation [13]. ΔeGFR was defined as initial eGFR minus
final eGFR. The annual decrease in eGFR was calculated
as (365 days) times ΔeGFR divided by the number of ob-
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Figure 1 Flow diagram in this study. Flow diagram illustrates the
selection of biopsy-proven IgA nephropathy patients followed for 5
to10 years that were included in this study.Analysis of pathological findings
Four observers (KM, NM, HM, HI) independently evalu-
ated the biopsy specimens under light microscopy with
hematoxylin and eosin (HE), periodic acid-Schiff (PAS),
periodic acid-silver methenamine (PAMS), and Masson’s
trichrome (MT) staining. All samples contained more
than 8 glomeruli, and 8 to 10 sliced sections per patient
were observed. The pathological data included the total
number of glomeruli, number of global sclerotic glom-
eruli, number of intact glomeruli remaining, number of
glomeruli with crescent formation, total number of
glomeruli with adhesions (i.e., the number of glomerular
tip adhesions plus the number of non-glomerular tip ad-
hesions), degree of mesangial proliferation, and degree
of interstitial damage. In order to focus on FSGS-like le-
sions, the glomerular tip domain is defined as the outer
25% of the tuft next to the origin of the proximal tubule,
based on the Columbia Classification [12]. In this classi-
fication of FSGS, glomerular tip lesions consist of tip
prolapse, tip adhesion, tip sclerosis, and intracapillary
foam cells in the tip domain (Figure 2). Glomerular tip
adhesion was defined as continuity of the extracellular
matrix between the glomerular tuft and Bowman’s cap-
sule in the tip domain, [12] which is often thickened.
Tubular atrophy and interstitial fibrosis were assessed
according to the criteria of El Karoui et al [10]. By light
microscopy, the severity of tubular atrophy, interstitial cel-
lular infiltration, and interstitial fibrosis, whichever the
greatest, was semiquantitatively scored on a scale of 0 to 4
(0, none; 1, 0–25%; 2, 26–50%; 3, 51–75%, and 4, >75%).
Statistical analysis
A stepwise logistic regression model was used with each
variable and ΔeGFR/days as the outcome variable. All
analyses were performed with SAS software version 9.1
(SAS Institute, Inc., Cary, NC, USA). Receiver operating
characteristic (ROC) curve analysis was used to deter-
mine the cut-off point for variables that showed signifi-
cant difference.
Subsequently, we compared two groups with or with-
out one factor using the chi-square test. Quantitative
values are expressed as means ± SD, unless otherwise
noted. Comparisons were performed using the Student’s
t test, Wilcoxon test, or Mann–Whitney U test as appro-
priate. P values less than 0.05 were considered statisti-
cally significant.
Results
Determination of factors influencing the decrease in eGFR
The backward elimination method was used to deter-
mine factors that strongly influence the decrease in
eGFR. Briefly, the F value was determined for age, blood
pressure, total protein, albumin, serum creatinine, eGFR,
total cholesterol, and daily amount of urinary protein at
the difinition of glomerular tip glomerular tip prolapse glomerular tip adhesion
glomerular tip sclerosis glomerular tip foam cells
Figure 2 Definition of glomerular tip and types of glomerular tip lesions. The glomerular tip is defined as the outer 25% of the tuft next to the
origin of the proximal tubule, based on the Columbia Classification. Glomerular tip prolapse means that some component of the glomerulus, such as
the basement membrane or the mesangial cells, is prolapsing into the proximal tubules. Glomerular tip adhesion is defined as a continuity of the
extracellular matrix between the glomerular tuft and Bowman’s capsule in the tip domain. Glomerular tip sclerosis is defined as segmental sclerosis in
a portion of the glomerular tip. Glomerular tip foam cells refer to the presence of foam cells in a portion of the glomerular tip.
Table 1 Six clinicopathologic parameters associated with
progression of IgA nephropathy identified through




F(6.50) = 4.202565, P = 0.001692,
R2 = 0.335242
β p value
Serum albumin −0.23405 0.1380
Diastolic blood pressure 0.292789 0.0244
Initial eGFR 0.633544 0.0002
Global sclerosis 0.310904 0.0190
Total glomerular adhesion −0.22385 0.1419
Glomerular tip adhesion 0.398646 0.0043
eGFR; estimated glomerular filtration rate (ml/minute per 1.73 m2).
Total glomerular adhesion: glomerular tip adhesion plus adhesions in other
parts of the glomerulus.
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glomeruli, number of glomeruli with crescent formation,
glomerular adhesion, or glomerular tip adhesion, which
were divided by the number of glomeruli observed, and
the tubulointerstitial damage score as defined in the
Methods. Factors with the smallest F value were elimi-
nated one by one. As a result, 6 factors remained: serum
albumin, diastolic blood pressure, eGFR, number of glo-
bally sclerotic glomeruli, glomerular adhesion, and glom-
erular tip adhesion / the number of glomeruli observed.
Based on the multiple linear regression analysis, p values
for these 6 factors were determined. The p value of
eGFR at the time of kidney biopsy (p = 0.000202) was
the lowest, and the p value of glomerular tip adhesions
(p = 0.004) was lower than the remaining 4 factors: serum
albumin (p = 0.138), diastolic blood pressure (p = 0.024),
global sclerosis (p = 0.019), and total glomerular adhesion
(p = 0.14) (Table 1).
Appearance of glomerular tip adhesions
Glomerular tip adhesions were present in 9 of 57 pa-
tients (15.8%) (Figure 2). Since 816 glomeruli were ob-
served in these 57 patients, the prevalence of glomerular
tip adhesions was 1.3% of all observed glomeruli. In
these 9 patients, there were 11 out of 175 glomeruli with
glomerular tip adhesions, yielding a 6.3% incidence
(Table 2). Thus, the presence of glomerular tip adhesions
has low sensitivity but high specificity for the progression
of IgA nephropathy. Figure 3A and 3B demonstrateglomerular tip adhesions in patients without glomerular
tip prolapse. Glomerular tip adhesions accompanied by
segmental glomerular sclerotic changes are shown in
Figure 3C and 3D. Mild mesangial proliferation was found
in 4 of 9 patients with glomerular tip adhesions. Almost
half of the patients with glomerular tip adhesions had evi-
dence of segmental glomerulosclerosis, which is compat-
ible with the pathological findings in FSGS. Figure 4
shows glomerular tip prolapse and FSGS, which differ
from glomerular tip adhesions.

























Case 1 12 2 0 5 2 0 1 3 2.36
Case 2 18 0 0 3 2 1 0 1 2.88
Case 3 8 0 0 1 1 0 0 2 6.44
Case 4 20 8 0 5 1 0 0 3 2.92
Case 5 24 0 6 3 1 0 0 1 2.38
Case 6 15 0 8 8 1 0 0 4 3.33
Case 7 30 1 1 1 1 0 0 1 -0.51
Case 8 8 0 1 2 1 0 0 2 12.18
Case 9 40 3 0 5 1 1 0 1 5.15
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glomerular tip adhesions
There were no significant differences between groups
with (n = 9) and without glomerular tip adhesions
(n = 48) in terms of age, sex, systolic blood pressure,Figure 3 Glomerular tip adhesions in each patient. “V”, “U”, and “Asteris
respectively. A. In Patient 1, a glomerular tip adhesion is seen at 6 o'clock (
at 4 and 8 o'clock (PAMS stain, 200×). C. In Patient 3, a glomerular tip adhe
at 8 o’clock (PAS stain, 200×). D. In Patient 4, a glomerular tip adhesion wit
Patient 5, a glomerular tip adhesion is seen at 6 o’clock, and hypercellularit
F. In Patient 6, a glomerular tip adhesion is observed at 9 o’clock, with mild
tip adhesion is seen at 7 o’clock (PAMS stain, 200×). H. In Patient 8, glomerula
glomerular tip adhesions are observed at 5 and 7 o’clock, (PAS stain, 200×).diastolic blood pressure, total serum protein, serum albu-
min, blood urea nitrogen, serum creatinine, eGFR, and
proteinuria. There was a tendency towards hypercholes-
terolemia in the group with glomerular tip adhesions
(two-sided p = 0.064; one-sided p = 0.032) (Table 3).k” mean vascular pole, urinary pole, and glomerular tip adhesion,
PAS stain, 200×). B. In Patient 2, glomerular tip adhesions are observed
sion with segmental sclerotic lesions of the mesangial area is observed
h segmental sclerosis is present at 6 o'clock (PAMS stain, 200×). E. In
y is observed in the upper portion of the glomerulus (PAS stain, 200×).
mesangial proliferation (PAS stain, 200×). G. In Patient 7, a glomerular
r tip adhesions are observed at 7 o’clock (PAS stain, 200×). I. In Patient 9,
Figure 4 Glomerular tip prolapse and glomerular tip adhesions accompanied by segmental sclerosis. A and B. Glomerular tip prolapse,
which is distinct from glomerular tip adhesions, in patients excluded from the present study. The dotted line indicates the border between the
glomerulus and the proximal tubules. The glomerular component prolapses into the tubular area (PAMS stain, 200×). C and D. In this glomerulus
with a glomerular tip adhesion, the upper portion shows evidence of segmental sclerosis (C: PAMS stain, 200×; D: AZAN stain, 200×).




Number of patients 9 48
Age (years) 38.7 ± 16.9 37.1 ± 14.6 n.s
Sex (M:F) 4:5 15:33 n.s
Systolic BP (mmHg) 134.7 ± 18.4 135.8 ± 22.4 n.s
Diastolic BP (mmHg) 82.4 ± 15.5 80.4 ± 14.1 n.s
Total protein (g/dl) 6.3 ± 0.7 6.6 ± 0.8 n.s
Albumin (g/dl) 3.9 ± 0.6 3.9 ± 0.5 n.s
Urea nitrogen (mg/dl) 15.1 ± 4.7 16.0 ± 8.5 n.s
Creatinine (mg/dl) 0.90 ± 0.27 1.02 ± 0.77 n.s
Total cholesterol (mg/dl) 230.6 ± 42.3 196.3 ± 41.7 0.064
Proteinuria (g/day) 1.39 ± 0.96 1.06 ± 1.24 n.s
Initial eGFR (ml/min/1.73 m 2) 78.9 ± 37.4 72.3 ± 32.9 n.s
Final eGFR (ml/min/1.73 m 2) 51.4 ± 38.4 62.1 ± 34.0 n.s
Observation period (days) 2894 ± 739 2768 ± 593 n.s
Annual decrease of eGFR 4.13 ± 3.58 1.49 ± 2.89 0.015
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The initial and the final eGFR were 78.9 ± 37.4 and
51.4 ± 38.4 ml/min/1.73 m2 in the group with glome-
rular tip adhesions, and 72.3 ± 32.9 and 62.1 ± 34.0
ml/min/1.73 m2 in the group without glomerular tip
adhesions, respectively. There were no significant differ-
ences between the two groups in terms of initial and
final eGFR. However, within each group, significant differ-
ences were observed between the initial and final eGFR
(p = 0.0019 and p = 0.0011, respectively) (Table 3, Figure 5).
The annual decrease in eGFR
The annual decrease in eGFR, which are calculated as 365
(days) times ΔeGFR/observed days was 4.13 ± 3.58 in the
9 patients with glomerular tip adhesions and 1.49 ±
2.89 ml/min/1.73 m2 in the 48 patients without glomerular
tip adhesions (p = 0.015) (Table 2), which means that pa-
tients with glomerular tip adhesions have a 2.77-fold more
rapidly progressive course than patients without glomeru-
lar tip adhesions. This finding is reasonable, because when
we first analyzed the factors predictive for a decrease in
eGFR, or progression of renal function, glomerular tip ad-
hesions were identified as one of predictive factors.
The relationship between the glomerular tip adhesion
and other pathological changes
There is no relationship between the group with and
without glomerular tip adhesions with respect to thetotal number of glomerular adhesions and the degree
of interstitial damage. In addition, there are no signifi-
cant differences among patients with glomerular tip
adhesions and other pathological findings. This finding
means that glomerular tip adhesion is a predictive
factor independent of the degree of interstitial damage
(Table 1).
eGFR eGFR




Figure 5 Changes in initial and final eGFR in IgA nephropathy patients with (n = 9) or without (n = 48) glomerular tip adhesions.




Therapy Patient (%) Patient (%)
9 (100) 48 (100)
Steroid only 2 (22.2) 3 (6.3)
Tonsillectomy only 1 (11.1) 3 (6.3)
Tonsillectomy plus steroid pulse 3 (33.3) 20 (41.7)
Angiotensin converting enzyme-inhibitor 3 (33.3) 10 (20.8)
Angiotensin II receptor blocker 6 (66.7) 25 (52.1)
No therapy 1 (11.1) 9 (18.8)
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Serum cholesterol was 230.6 ± 42.3 mg/dl in the group
with glomerular tip adhesions and 196.3 ± 41.7 mg/dl in
the group without glomerular tip adhesions; this differ-
ence was significant in a one-sided test (p = 0.034) but not
in a two-sided test (p = 0.064) (Table 3). This suggests that
high levels of serum cholesterol or cholesterol-related sub-
stances may be associated with glomerular tip adhesions,
although in theory the pathological changes do not influ-
ence serum cholesterol levels.
The relationship between the glomerular tip adhesions
and therapy
Table 4 shows the main therapies the 57 IgA nephropa-
thy patients underwent, based on review of available
data. There is no significant difference between the
groups with and without glomerular tip adhesions in
terms of the number of patients treated with corticoste-
roids only (2/9 versus 3/48), tonsillectomy only (1/9 ver-
sus 3/48), tonsillectomy plus steroid pulse therapy (3/9
versus 20/48), angiotensin-converting enzyme inhibitors
(ACE-Is) (3/9 versus 10/48), angiotensin II receptor
blockers (ARBs) (6/9 versus 25/48), or observation (1/9
versus 9/48). Patients receiving aggressive therapy, such
as steroid pulse therapy, tonsillectomy, and tonsillec-
tomy plus pulsed steroids, included 6 of 9 (66.7%) pa-
tients, and 26 of 48 (54.2%) patients, respectively. Thetype of therapy may not have been identified as a pre-
dictive factor in the present study because of the small
sample size.
Discussion
The present study demonstrates that the presence of ad-
hesions in the glomerular tip, but not adhesions in the
glomerulus overall or crescent formation, is a specific
predictive factor for progression of IgA nephropathy.
This is the first report regarding the importance of
glomerular tip adhesions, which are associated with
FSGS. The present data did not identify interstitial
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the relatively early stages of IgA nephropathy, although
these have been reported as important factors in
progression.
Glomerular tip adhesions were first described as a
finding in FSGS. However, the 2009 Oxford classification
of IgA nephropathy [14] commented that the combined
term “segmental sclerosis or adhesion” should be used,
because there was no consensus on the definition of ad-
hesions among pathologists. This international study
group reported that in an analysis of 265 patients from
all over the world, more than a moderate degree of
mesangial proliferation, segmental glomerulosclerosis,
and more than 26% interstitial damage are predictive
factors for the progression of IgA nephropathy. There
was no detailed information which lesion is more impact,
glomerular adhesions or segmental glomerulosclerosis, be-
cause there was no discrimination of adhesions from seg-
mental sclerosis.
Regarding FSGS, the Columbia classification defined
the glomerular tip domain as the outer 25% of the tuft
next to the origin of the proximal tubule [12]. Generally,
glomerular tip lesions consist of tip prolapse, tip adhe-
sion, tip sclerosis, and intracapillary foam cells in the tip
domain. There are several reports about the combin-
ation of IgA nephropathy and FSGS-like lesions. In
1996, Haas [15] compared 18 of 244 (7.4%) IgA ne-
phropathy patients with focal segmental sclerosis andA B
E
Figure 6 Possible mechanism through which glomerular tip adhesion
glomerulus. B. A glomerular tip adhesion interferes with the flow of origina
adhesion and hyperfiltration on the intact side. C. Segmental glomeruloscle
with the glomerular tip adhesion. D. Hyperfiltration in other areas of the gl
changes finally induce global glomerular sclerosis.capillary collapse, named as FSGS-like IgA nephropa-
thy, with typical idiopathic FSGS patients on clinical
parameters. There were no significant difference be-
tween the two groups in terms of proteinuria (5.5 ± 2.8
versus 7.7 ± 5.8 g/day), serum creatinine (1.6 ± 1.2 ver-
sus 1.9 ± 1.5), and prognosis. He commented that IgA
nephropathy patients with FSGS-like lesions have a
similarly poor prognosis as idiopathic FSGS patients. In
1997, Haas demonstrated that the presence of periph-
eral glomerular capillary deposits has no prognostic
value, based on an electron microscopic study of 244
patients [16]. He did not determine the critical patho-
logical findings such as segmental sclerosis or adhesion.
The present study points out that the presence of
glomerular tip adhesions is an independent risk factor
for decreasing kidney function in IgA nephropathy. The
prevalence of glomerular tip adhesions, approximately
15.8% (9 of 57) of patients, and 1.3% (11 of 816) of ob-
served glomeruli, suggests that the presence of glomeru-
lar tip adhesions has low sensitivity and high specificity
for the progression of IgA nephropathy. Further analysis
will reveal the importance of glomerular tip adhesions in
the progression of IgA nephropathy.
Figure 6 illustrates a possible mechanism through
which glomerular tip adhesions affect the progression of
IgA nephropathy. Glomerular tip adhesions interfere
with the flow of original urine, meaning that hypofiltra-
tion occurs on the side of the glomerular tip adhesionC
D
s influence the progression of IgA nephropathy. A. Intact
l urine, leading to hypofiltration on the side of glomerular tip
rosis occurs due to decreased intraglomerular pressure on the side
omerulus produces a new glomerular tip adhesion. E. The above
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erulus (Figure 6A). Segmental glomerulosclerosis may
develop due to the decreased intraglomerular pressure
on the side of the glomerular tip adhesion (Figure 6C).
Subsequently, hyperfiltration produces a new glomerular
tip adhesion elsewhere in the glomerulus (Figure 6D).
These changes finally induce global glomerular sclerosis
(Figure 6E).
Many reports have demonstrated that young age, pro-
teinuria, systolic blood pressure, hypoalbuminemia, ini-
tial eGFR, and severe pathological grade are predictive
factors in IgA nephropathy progression [17]. The present
study identified the presence of glomerular tip adhe-
sions as an additional predictive factor. Sampling bias,
resulting in 30 out of 57 patients (52.6%) with less than
1.0 g/day of urinary protein and 10 out of 57 patients
(17.5%) with more than 2.0 g/day of urinary protein in
the present study, may have contributed to proteinuria
was not being identified as a risk factor. These results
suggest that the presence of glomerular tip adhesions is
a more important factor than proteinuria in the early
stages of IgA nephropathy.
Hypercholesterolemia showed a weak relationship
with the presence of glomerular tip adhesions (two-side
p = 0.06; one-side p = 0.03), even though hypercholes-
terolemia was not a risk factor for the overall progres-
sion of IgA nephropathy. There are several possibilities:
one is that hypercholesterolemia directly influences
glomerular tip adhesions, another is that substances re-
lated to serum cholesterol induce formation of glomerular
tip adhesions. Regarding the first hypothesis, lipoprotein
abnormalities are a putative risk factor of the progression
of chronic renal insufficiency in humans [18]. Recently,
apolipoprotein L1 (APOL1) has been reported to be asso-
ciated with FSGS lesions, a progressive course in HIV-
related nephropathy, and chronic kidney disease [19,20].
One controversial study reported that hyperlipidemia is
not an independent predictor of long-term outcome
[21]. In the present study, hypercholesterolemia itself
was not identified as a predictive factor for progression
of IgA nephropathy. Further study is needed to clarify
the relationship between APOL1 and glomerular tip
adhesions. As for the latter possibility, asymmetric
dimethylarginine (ADMA), an endogenous antagonist
of nitric oxide (NO) biosynthesis via inhibition of the
active site of NO synthase, is a strong candidate; high
serum levels of ADMA have been reported to be associ-
ated with hypercholesterolemia and declining kidney
function in IgA nephropathy [22]. LDL cholesterol is
reported to up-regulate ADMA in endothelial cells
[23,24]. Although Fuzimi-Hayashida et al. [22] found
high levels of ADMA in progressive IgA nephropathy
patients, unfortunately they did not comment on the
relationship between ADMA and segmental sclerosis orglomerular tip adhesions. Further study is needed to
elucidate the relationship between serum ADMA levels
and glomerular tip adhesions.
Limitations
The present study is limited by its single center, retro-
spective nature and the relatively small sample size of 57
patients, because we selected patients who could be suf-
ficiently followed for 5 to 10 years after renal biopsy.
However, the present study suggests the importance of
glomerular tip adhesions, which may be related to
FSGS-like lesions, in the progression of IgA nephropa-
thy. Future studies with more patients and participating
centers are needed to determine whether glomerular tip
adhesions are a prognostic factor in IgA nephropathy.
Conclusions
Glomerular tip adhesions predict decreased eGFR in rela-
tively early stages of IgA nephropathy. High levels of serum
total cholesterol may affect glomerular tip adhesions, even
though hypercholesterolemia was not identified as a pre-
dictive factor for progression of IgA nephropathy.
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